CHAT and Alzheimer disease: Among the AD group, a significantdifference was observed in the plasma ChAT activity with respect to the SNP,rs1880676. The AD carriers of the G allele had significantly lowerplasma ChAT activity than the non-carrier AD group (p = 0.002, Table 3).